Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
IMABIOTECH<br />
B<strong>at</strong>iment SN3 Cite Scientifique<br />
59655 VILLENEUVE D’ASCQ - FRANCE<br />
Phone: +33 6 32 94 03 51<br />
Fax: +33 3 20 43 40 54<br />
Email: stauber.jon<strong>at</strong>han@imabiotech.com<br />
Web site: www.imabiotech.com<br />
Contact: Jon<strong>at</strong>han STAUBER<br />
ImaBiotech offers services and products with an innov<strong>at</strong>ive technology of mass<br />
spectrometry imaging.<br />
ImaBiotech is a contract research organiz<strong>at</strong>ion (CRO) which provides Mass<br />
Spectrometry Imaging services for preclinical research (ADME and pharmacokinetics<br />
studies). With innov<strong>at</strong>ions and improvement of this technology, ImaBiotech also<br />
develops a new tool for immunodiagnostics.<br />
IMMUNID TECHNOLOGIES<br />
17 rue des Martyrs<br />
38054 GRENOBLE Cedex 09 - FRANCE<br />
Phone: +33 4 38 78 57 70<br />
Fax: +33 4 38 78 58 37<br />
Email: services@immunid.com<br />
Web site: www.immunid.com<br />
Contact: Isabelle TANNEAU<br />
ImmunID is a molecular diagnostics company th<strong>at</strong> uses the immune repertoire as a<br />
dynamic biomarker. Our team is dedic<strong>at</strong>ed to bringing solutions for the assessment<br />
of the efficacy and safety of immunomodul<strong>at</strong>ors during clinical trials and for p<strong>at</strong>ient<br />
str<strong>at</strong>ific<strong>at</strong>ion, in the areas of oncology and infectious diseases. ImmunID recently<br />
introduced the innov<strong>at</strong>ive concept of Divpenia ® (www.divpenia.com), a clinical st<strong>at</strong>e<br />
of reduced T & B lymphocytes immune diversity th<strong>at</strong> correl<strong>at</strong>es with a higher risk<br />
of infection and mortality. Divpenia ® can be used as a biomarker for early diagnosis,<br />
prognosis, response to tre<strong>at</strong>ment monitoring and p<strong>at</strong>ient str<strong>at</strong>ific<strong>at</strong>ion.<br />
43
Change language